Your browser doesn't support javascript.
loading
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
Lee, Wan-Hsuan; Lin, Chien-Chin; Tsai, Cheng-Hong; Tien, Feng-Ming; Lo, Min-Yen; Ni, Sao-Chih; Yao, Ming; Tseng, Mei-Hsuan; Kuo, Yuan-Yeh; Liu, Ming-Chih; Tang, Jih-Luh; Sun, Hsun-I; Chuang, Yi-Kuang; Chou, Wen-Chien; Hou, Hsin-An; Tien, Hwei-Fang.
Afiliación
  • Lee WH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Lin CC; Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan.
  • Tsai CH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Tien FM; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Lo MY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Ni SC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Yao M; Department of Medical Education and Research, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
  • Tseng MH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Kuo YY; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Liu MC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Tang JL; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Sun HI; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
  • Chuang YK; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Chou WC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hou HA; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.
  • Tien HF; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.
Am J Hematol ; 98(3): 398-407, 2023 03.
Article en En | MEDLINE | ID: mdl-36588411

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos